Farther Finance Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Buy
1,260
+838
+199% +$71K ﹤0.01% 2619
2026
Q1
$35.2K Sell
422
-429
-50% -$35.2K ﹤0.01% 3245
2025
Q4
$78K Buy
851
+459
+117% +$43.9K ﹤0.01% 2505
2025
Q3
$37.1K Buy
392
+146
+59% +$13.7K ﹤0.01% 2624
2025
Q2
$25.8K Buy
246
+172
+232% +$16.3K ﹤0.01% 2524
2025
Q1
$6.44K Buy
74
+3
+4% +$308 ﹤0.01% 2938
2024
Q4
$6.81K Sell
71
-222
-76% -$20.7K ﹤0.01% 2539
2024
Q3
$24K Buy
293
+237
+423% +$18.3K ﹤0.01% 2001
2024
Q2
$4.85K Buy
56
+21
+60% +$1.7K ﹤0.01% 2410
2024
Q1
$2.86K Buy
35
+3
+9% +$234 ﹤0.01% 2339
2023
Q4
$2.12K Buy
32
+11
+52% +$763 ﹤0.01% 2406
2023
Q3
$1.53K Buy
21
+11
+110% +$743 ﹤0.01% 1950
2023
Q2
$631 Buy
+10
New +$580 ﹤0.01% 2088

Other funds holding HQY

Farther Finance Advisors's HQY Position: Q2 2026 in Review

Farther Finance Advisors increased its HealthEquity (HQY) stake by 199% in Q2 2026, buying an estimated $71K and bringing the position to 1,260 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Farther Finance Advisors first reported a position in HQY in Q2 2023 and has held it in 13 quarters since. 56 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Farther Finance Advisors held 1,260 shares of HealthEquity worth $114K as of Q2 2026.
  • Farther Finance Advisors bought 838 HealthEquity shares in Q2 2026, an estimated $71K.
  • HealthEquity made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2619 holding.
  • Farther Finance Advisors first reported a position in HealthEquity in Q2 2023 and has held it in 13 quarters since.
  • 56 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.